BIOMAT Database Logo BIOMAT Database Logo

Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study. 2003

Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

OBJECTIVE Methotrexate is a major component of current treatment regimens for children with acute lymphocytic leukemia (ALL). Potential mechanisms of methotrexate resistance include impaired drug uptake, decreased drug retention, and dihydrofolate reductase (DHFR) amplification. The purpose of this study was to assess whether reduced folate carrier (RFC) and DHFR expression in untreated leukemic blasts correlated with outcome. METHODS Quantitative real-time RT-PCR was used to measure RFC and DHFR mRNA expression in leukemic blasts from 40 newly diagnosed patients with ALL obtained in a blinded fashion from Children's Cancer Group studies. RESULTS Low RFC expression at diagnosis correlated significantly with an unfavorable event free survival. Surprisingly, low, not high, DHFR expression correlated significantly with an unfavorable event-free survival. Proliferative cell nuclear antigen (PCNA) expression demonstrated a weak inverse relationship between sample PCNA and DHFR or RFC expression, suggesting that DHFR and RFC expression may be markers for factors other than drug resistance. CONCLUSIONS These results suggest that impaired transport may be an important mechanism of intrinsic methotrexate resistance in ALL, and DHFR expression also may be an important prognostic factor in ALL. Additional studies are necessary to clarify the mechanism for the correlation of low DHFR expression with poor outcome.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Reduced folate carrier and methylenetetrahydrofolate reductase gene polymorphisms: associations with clinical outcome in childhood acute lymphoblastic leukemia.
July 2009, Leukemia,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity.
September 2010, Cancer research and treatment,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.
June 2003, Molecular cancer therapeutics,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
May 2009, The Journal of pediatrics,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
February 1997, Blood,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.
September 1998, Clinical cancer research : an official journal of the American Association for Cancer Research,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
January 2004, Annals of oncology : official journal of the European Society for Medical Oncology,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.
January 1998, Pediatric hematology and oncology,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
[Surface marker analysis with monoclonal antibodies in acute non-lymphocytic leukemia in childhood. Children's Cancer and Leukemia Study group].
May 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Adam S Levy, and Harland N Sather, and Peter G Steinherz, and Rebecca Sowers, and Mei La, and Jeffrey A Moscow, and Paul S Gaynon, and Fatih M Uckun, and Joseph R Bertino, and Richard Gorlick, and
Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
January 2007, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!